[Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France]

[Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France]. Benachi, A.; Letourneau, A.; Kleinfinger, P.; Senat, M. V.; Gautier, E.; Favre, R.; Bidat, L.; Houfflin-Debarge, V.; Querol, V.; Bouyer, J.; Costa, J. M.; pour le groupe, Sehda. J Gynecol Obstet Biol Reprod (Paris). 2015; : . doi:10.1016/j.jgyn.2015.08.003
Article